MO SB386

Expands qualifying conditions for hemp extract beyond intractable epilepsy to include cancer, HIV/AIDS, ALS, Parkinson's disease, multiple sclerosis, spinal cord damage, inflammatory bowel disease, neuropathies, Huntington's disease, PTSD, and related complications such as chronic pain, severe nausea, and seizures

Allows any licensed Missouri physician (not just neurologists) to recommend hemp extract for patients with qualifying serious conditions, provided the physician has relevant training or experience

Increases the number of licensed cultivation and production facilities from 2 to a phased expansion: 5 facilities in 2016, 8 in 2017, and 10 in 2018 and thereafter

Requires cultivation facility applicants to have been domiciled in Missouri for at least five years, while grandfathering facilities licensed before August 28, 2015

Protects healthcare entities and individuals from state adverse actions (civil/criminal prosecution, licensing penalties) when acting in good faith on a neurologist or practitioner's hemp extract recommendation